诺诚健华:2023年股东周年大会会议资料

http://ddx.gubit.cn  2023-05-04  诺诚健华(688428)公司公告

InnoCare Pharma Limited

9969(1)(2)(3)(4)

(5)(6)(7)(8)(9)(10)

(11)

(12)(13)

AGM-1AGM-7( www.hkexnews.hk)( www.innocarepharma.com)

18317M

– i –

...... 1

...... 3

...... 9

1. ......................................................10

2. .........................................10

3. .................................10

4. .................................11

5. ...................................11

6. ..............................................11

7. .......................................12

8. .......................................13

9. ........................13

10. ...............................4811. ...... 48

12. .............50

13. ................52

14. .....................................54

15. ..........................................54

16. ..........................54

17. .......................................55

18. ..........................................55

19. ..............................................55

20. ............................................56

21. ..................................................56

22. ..................................................56

– ii – ...... I-1

...... II-1 ..................................III-1 ...... IV-1

...... V-1

...... VI-1 ..............................VII-1 ...............................................AGM-1

1.

(i)

“” http://meetings.computershare.com/InnocareAGM2023

(ii)

(iii)

(1)

“”(2)

2.

3.

(www.hkexnews.hk)(www.innocarepharma.com)

18317M

18317M

(852) 2862 8555

(852) 2865 0990

www.computershare.com/hk/contact

(www.hkexnews.hk)(www.innocarepharma.com)

10%10%

”“

“”

“”“”“”

AGM-1AGM-7“”

“”14A.06(2)“”

“”

“”

“”

9969688428“”“”“”“”“”14A.06(7)“”“”“”

“”“”7,209,000

80.56%

“”

“”“”

“”“”“”“”“”

0.000002

“”

“”

“”

“”

“”

“”

“”“”

Jisong CuiRenbin Zhao

5%

“”

“”

“”1,739,750

19.44%

“”

“”“”

“”

0.000002

“”“11.

“”“”“”

“”

0.000002

“”“”“”“”“”

“”“”“”

1.01

“”

“”

“”“”

“”

“”

“%”

InnoCare Pharma Limited

9969Ogier Global (Cayman) Limited89 Nexus Way, Camana BayGrand Cayman, KY1-9009Cayman Islands

(1)(2)(3)(4)

(5)(6)(7)(8)(9)(10)

(11)(12)(13)

1.AGM-1AGM-7

(1)(2)(3)

(4)(5)

(6)(7)

(8)(9)

(10)

(11)(13)

(12)2.

(http://www.sse.com.cn)(http://www.hkexnews.hk)(www.innocarepharma.com)

(http://www.hkexnews.hk)(http://www.sse.com.cn)(www.innocarepharma.com)3.

4.

5.

20%1,499,673,235264,648,2175

299,934,64752,929,64376520%

10%

6.

114.(a)

7.

(a)

(b) 3.13

(c)

3.13

8.

9.

“(i)”

(i)

30,629,507

1.74%

51,481,607

2.92%

“”

“”8,948,750

0.51%

“11.

“”“”

10%10%

“”

3.43%(i)(ii)

20%

10%1%

0.1%

894.875

176,432.14520.51%

720.900

176,432.14520.41%

80.56%173.975

176,432.14520.10%19.44%

1.

2.

5%

1 115

93912.25%(1)(2)

5%

2. 12

0.1%

1.

165.00018.44%0.09%

50.0005.59%0.03% 40.0004.47%0.02%

255.00028.50%0.14%2.112465.90052.06%0.26%

720.90080.56%0.41%3.

173.97519.44%0.10%

894.875100.00%0.51%

1%

0.1%

20%

10%

5%

1.

2. 5

“”

1212

1.

(1)

(2)

2.

1.

2.

3.

4.

25%

25%

25%

25%

25%

25%

25%

25%

1.

25%

2.

6.95

6.95

1. 1

13.5750.00%6.79

2. 20

2020

13.6450.00%6.82

3. 60

6060

13.1650.00%6.58

4. 120

120120

13.8950.00%6.95

1.

(1)

(2)

(3) 36

(4)(5)2.

(1) 12

(2) 12

(3) 12

(4)

(5)(6)

“”

(1)

(2)

(3) 36

(4)(5)

(1) 12

(2) 12

(3) 12

(4)

(5)(6)

ABC

100%80%70%

IIIIII

IIIIII

IIIIII

ABC

100%80%70%

IIIIII

21.5

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

“”

ABC

100%80%70%

IIIIII

21.5

IIIIII

IIIIII

ABC

100%80%70%

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

ABC

100%80%70%

IIIIII

IIIIII

IIIIII

ME & ME AboveME-BE

ME & ME

AboveME-BE

100%80%0

=××

4 6

5%

4 60

1212

(1)

(2)

(1)(2)

QQ

×1nQ

nQ

QQ

×P

×1n÷P

P

×nQ

P

P

nQ

QQ

×nQ

n1nQ

PP

÷1nP

nP

PP

×P

P

×n÷[P

×1n]P

P

P

nP

PP

÷nP

nP

PP

-V

P

VPP1

1122

1122

Black-Scholes

7,209,000

1 13.53

2 12243648

3 31.9489% 34.9121%35.7182%36.3346%

122436484 2.1754%2.4056%2.4887% 2.5758%

1234

7,209,0005,217.511,543.501,936.371,058.37533.97145.31

1.

2.

3.

4.

5.

6.

7.

8.

1.

2.3.

4.

5.

6.

7.

8.

9.

1.

(1)

(2)

(3) 36

(4)(5)2.

(1)(2)

3.

1.

(1) 12

(2) 12

(3) 12

(4)

(5)(6)2.

3.

4.

5.

(1)

(2)

6.

(1)

(2)

7.

10.

11.

8,948,750

0.51%

3.43%(i)(ii)

“9.”

62,193,812.508,948,750

6.95

“VI.”

0.000002

17.8975

(1)264,648,217273,596,9671,499,673,2351,499,673,2351,764,321,4521,773,270,202

(1)

(1)

75.40%75.52%

(1)

264,648,217

2,778.82

1.“”

2.3.4.5.

12.

(1)

(2)

(3)

(4)

(5)

(6)(7)

(8)

(9)

(10)

(11)

(12)

(13)

13.

(i)

(i)121%(ii)

0.1%

3.43%(i)(ii)

(ii)

17.03(13)

17.03(13)

17.03(13)

17.03(13)

(i)

“”“”

(ii)

(iii)8,948,750

1,764,321,4520.51%(iv)

(iii)

8.2013.26

14.

15.

(i)(ii)

16.

17.

183171712-171618.

AGM-1AGM-7

(i)(ii)(iii)

19.

( www.hkexnews.hk)( www.innocarepharma.com)

20.

(i)(ii)(iii)

(iv)

21.

22.

(i)(ii)(iii)

(iv)

(i)

(ii)(iii)

(iv)

(v)“”

(i)(ii)(iii)(iv)

(v)

– I-1 –

20222022“”

2022

2022

2022Tafasitamab13I/II/III1.0

2.0

2022

202213

12022.03.232322022.03.29232022.05.05142022.05.072

– I-2 –

52022.05.11162022.06.01372022.07.20182022.08.08392022.08.192102022.10.124112022.11.112122022.12.071132022.12.231

1 A

277,881.562022

1A

– I-3 –

A

A

– I-4 –

e

20221

2022

20225

20222

20222

– I-5 –

2023

2023

2023426

– II-1 –

13.51(2)

Ph.D.54

ShenzhouTianchen Technology Inc.

?(Johns Hopkins University)

XV116,839,593

Oriza Cowin

– II-2 –

688578

0992602171

XV

Ph.D.77

??“”

?

– II-3 –

??

1349Zai Lab LimitedZLAB

96881801

600557

30,000

XV

3.13

– II-4 –

(i)(ii)(iii)

13.51(2)(h)(v)

– III-1 –

(a)(b) 10.06(1)(b)

(c)

10.06(1)(c)

1,499,673,235264,648,217

10%

149,967,32310%

– III-2 –

– III-3 –

HHLR Advisors, Ltd.208,671,22211.83%HHLR Advisors, Ltd.12.93%

13.9410.00

11.109.56

14.4810.04

14.7810.80

12.4410.36

12.027.86

9.957.20

13.009.00

14.8010.52

15.9013.24

15.428.51

9.507.86

10.907.90

– IV-1 –

A688428 A

09969 B

– IV-2 –

– IV-3 –

(InnoCare Pharma Limited)

“”“”

894.875

176,432.14520.51%

720.900

176,432.14520.41%

80.56%173.975

176,432.14520.10%

19.44%

– IV-4 –

20%10%1%

0.1%

6.95

93912.25%

– IV-5 –

12 12 12

– IV-6 –

– IV-7 –

...... IV-2

...... IV-3

...... IV-8

...... IV-10

...... IV-12

...... IV-13

...... IV-15

...... IV-17

...... IV-22

...... IV-23

...... IV-32

...... IV-36

...... IV-39

...... IV-41

...... IV-43

...... IV-47

– IV-8 –

InnoCare Pharma Limited

– IV-9 –

2023420

(InnoCare Pharma Limited)

– IV-10 –

30,629,507

1.74%

51,481,6072.92%“”

“”“”

10%10%

– IV-11 –

“”,

20%

10%

0.1%

– IV-12 –

– IV-13 –

5%

93912.25%

5%

– IV-14 –

– IV-15 –

894.875

176,432.14520.51%

720.900

176,432.14520.41%80.56%

173.975

176,432.14520.10%19.44%

0.1%

1.

165.00018.44%0.09%

– IV-16 –

50.0005.59%0.03%

40.0004.47%0.02%

255.00028.50%0.14%2. 112

465.90052.06%0.26%

720.90080.56%0.41%3.

173.97519.44%0.10%

894.875100.00%0.51%

1%

120.1%

20%10%2 5%

– IV-17 –

6012

– IV-18 –

– IV-19 –

25%

25%

25%

25%

– IV-20 –

25%

25%

25%

25%

– IV-21 –

25%

– IV-22 –

6.95

6.95

113.57

50.00%6.79

20202013.64

50.00%6.82

60606013.16

50.00%6.58

120120120

13.8950.00%6.95

– IV-23 –

3 36

1 122 123 12

– IV-24 –

“”

3 36

1 122 123 12

– IV-25 –

A100%

B80%

C70%

IIIIII

IIIIII

IIIIII

– IV-26 –

A100%

B80%

C70%

21.5

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

– IV-27 –

A100%

B80%

C70%

IIIIII

IIIIII

IIIIII

“”

– IV-28 –

A100%

B80%

C70%

21.5

IIIIII

IIIIII

IIIIII

– IV-29 –

A100%

B80%

C70%

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

IIIIII

– IV-30 –

A100%

B80%

C70%

IIIIII

IIIIII

IIIIII

– IV-31 –

ME & ME AboveME-BE

ME & MEAboveME-BE

100%80%0=××

– IV-32 –

– IV-33 –

5%

– IV-34 –

– IV-35 –

– IV-36 –

Q = Q

× (1 + n)Q

nQ

Q = Q

× P

×(1 + n)÷ (P

+ P

× n)Q

P

P

nQ

Q = Q

× nQ

n1nQ

– IV-37 –

P = P

÷ (1 + n)P

nP

P = P

× (P

+ P

×n)÷ [P

× (1 + n)]P

P

P

nP

P = P

÷ nP

nP

P = P

– V

P

VPP1

– IV-38 –

– IV-39 –

1122

1122Black-Scholes

720.900

13.53

12243648

31.9489%34.9121%35.7182%36.3346%

12243648 2.1754%2.4056%2.4887%2.5758%1

– IV-40 –

7,209,0005,217.511,543.501,936.371,058.37533.97145.31

– IV-41 –

– IV-42 –

– IV-43 –

3 36

– IV-44 –

1 122 123 12

– IV-45 –

– IV-46 –

– IV-47 –

– V-1 –

“”

“”

“”

(InnoCare Pharma Limited)

– V-2 –

“”

ABC100%80%70%

I-III

I-III

I-III

– V-3 –

ABC100%80%70%

I-III

21.5

I-III

I-III

I-III

I-III

I-III

– V-4 –

ABC100%80%70%

I-III

I-III

I-III

“”

– V-5 –

ABC100%80%70%

I-III

21.5

I-III

I-III

I-III

I-III

I-III

– V-6 –

ABC100%80%70%

I-III

I-III

I-III

I-III

I-III

I-III

– V-7 –

ME &ME AboveME-BE

ME & MEAboveME-BE100%80%0=××

– V-8 –

– VI-1 –

14.14.

1.

0.1%

2.

1.

0.1%

2.

3.

– VI-2 –

– VII-1 –

1(b)

“”

“”

19613

1(b)

“”

“”

19613

– VII-2 –

5(a)5(a)

– VII-3 –

17(d)

17(d)

64(a)64(a)

– VII-4 –

1410

2120

1410

– VII-5 –

84A(a)

(b)

84A

(a)(b)

– VII-6 –

97(b)

97(b)

– VII-7 –

– VII-8 –

186(b)186(b)

– AGM-1 –

InnoCare Pharma Limited

9969

“”

1.

“”“”2.

3. (i)

(ii)(iii)4.“”5.

– AGM-2 –

6.

“(i) (iii)

(v)

“”(ii) (i)

(iii) (i)

(1) (v)(2)

(3)

(4)

– AGM-3 –

20%

“”

(i)(v)(ii)

(iv)

(v)

(a)“”(1)

(2)(i)(ii)

(iii)(b)“”

(1)(2)

(3)“”

– AGM-4 –

(c)“”

”7.

“(i) (ii)

(iv)

“”(ii) (i)

10%(iii) (i)(ii)(i)(ii)

(iv)

“”

(a)

– AGM-5 –

(b)

(c)

”8.

10%”9.10.11.12.

13.

14.

15.

16.

– AGM-6 –

17.

– AGM-7 –

(i) 567(ii)(iii)

(iv)

18317M

(v)

183171712-1716(vi) 2

(vii) 5(viii) 6

(ix)(x)


附件:公告原文